Michael Max Sachse Selected Research

Skin Neoplasms (Skin Cancer)

1/2022

MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma - An evaluation of the multicenter prospective skin cancer registry ADOREG.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Max Sachse Research Topics

Disease

2	Melanoma (Melanoma, Malignant) 01/2022 - 05/2021
1	Skin Neoplasms (Skin Cancer) 01/2022
1	Neoplasms (Cancer) 05/2021
1	Disease Progression 05/2021
1	Keratoacanthoma 08/2014
1	Wounds and Injuries (Trauma) 08/2013
1	Herpes Zoster Oticus (Geniculate Neuralgia) 04/2012

Drug/Important Bio-Agent (IBA)

2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 08/2014
1	Immune Checkpoint InhibitorsIBA 01/2022
1	pembrolizumabIBA 01/2022
1	IpilimumabIBA 01/2022
1	NivolumabIBA 01/2022
1	Acitretin FDA Link 08/2014
1	RetinoidsIBA 08/2014
1	CollagenIBA 08/2013
1	Acyclovir (Aciclovir)FDA LinkGeneric 04/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2012

Therapy/Procedure

3	Therapeutics 01/2022 - 04/2012
1	Immunotherapy 01/2022